307 institutions reported holding $3.49B of ARCUTIS BIOTHERAPEUTICS INC (ARQT) in SEC 13F filings for 2026-06-30. Largest institutional holders: SUVRETTA CAPITAL MANAGEMENT, LLC ($326.1M), BlackRock, Inc. ($276.5M), Frazier Life Sciences Management, L.P. ($258.9M), VANGUARD GROUP INC ($220.1M), Rubric Capital Management LP ($216.9M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30